News
-
8th October, 2020 - Press notes
A study by researchers from Hospital del Mar and the Hospital del Mar Medical Research Institute reveals the protective effect that 30 minutes of moderate physical activity per day can have, as recommended by the World Health Organisation. Multiplying this figure by four maximises the benefit, but, beyond this, there is no additional benefit. The study, published by the Revista Española de Cardiología (Spanish Journal of Cardiology), has been monitoring over 11,000 people for more than 7 years.
more information
-
October 2nd, 2020 - Press notes
Benign breast diseases (BBD), which are non-cancerous disorders of the breast, such as lumps, are known to increase the chances of subsequent breast cancer. Now a team of Hospital del Mar researchers have found that the way BBD is detected as part of a national screening programme is an indication of which are more likely to become cancerous.
more information
-
15/09/2020 - Press notes
This discovery may provide new treatment strategies and therapeutic targets for important diseases such as cancer or Alzheimer's
The research group of GPCR Drug Discovery at the Hospital del Mar Medical Research Institute (IMIM), in collaboration with the Indian Institute of Technology in Kanpur, has deciphered how nature adjusts the response of the human cell to abundant extracellular stimuli (e.g., smell, taste, light, hormones, etc.).
more information
-
September 3rd 2020 - Press notes
Arnau Busquets-García, an IMIM researcher, receives an ERC Starting Grant for scientific excellence.
more information
-
July 14th 2020 - Press release
The results of the study, published in Nature Methods, may facilitate the development of new drugs related to diseases such as cancer and Alzheimer's. The new tool provides access to a large number of atomic-level simulations, the most basic, of the behaviour of a crucial element in almost all human physiological responses. This work is the result of a study by a consortium of international research centres led by scientists at the Hospital del Mar Medical Research Institute, in collaboration with Pompeu Fabra University and the Paul Scherrer Institute in Switzerland, and with the support of the Autonomous University of Barcelona.
more information
-
July 9th 2020 - Press notes
Dr. Arnau Busquets, currently a Ramon y Cajal researcher in the IMIM's Integrated Pharmacology and Systems Neuroscience Research Group is one of the first authors of this work.
more information
-
June 30th 2020 - Press notes
The successful projects are "Obtaining antioxidant active substances from the carob pod and validating their therapeutic potential", which involves the company Euronutra, the IBIMA (Malaga Biomedical Research Institute), the IMIM (Hospital del Mar Medical Research Institute), and the CRG (Centre for Genomic Regulation); and the project "Development of a new therapy for Fragile X syndrome", in which the company Connecta Therapeutics, the IMIM, and the CRG are participating.
more information
-
June 3rd 2020 - Press release
This is a pioneering Data Analytics project in Spain, which will enable us to increase our knowledge of the evolution of COVID-19 and its interaction with patients with other pathologies based on the analysis of discharge reports. The initiative is the result of collaboration between Hospital del Mar, the technology company Bismart and Ferrer Laboratory and uses the artificial intelligence tool Bismart Folksonomy. In less than a month, a project has been launched with more than 34,000 hospital and emergency room discharges, 2,700 of which correspond to COVID-19 patients. This will allow an in-depth analysis of their evolution and the relationship of the infection with other basic pathologies.
more information
-
May 28th 2020 - Press notes
The MINDUP project began in January 2020 to support SMEs in the mental health care of their workers. Now adapting to the COVID-19 pandemic and highlighting its usefulness in current circumstances.
more information
-
May 25th 2020 - Press notes
The company Chemotargets -based in the Barcelona Science Park and a leader in in the global market as a provider of intelligence and drug design prediction platform- has signed a strategic agreement with the Hospital del Mar Medical Research Institute (IMIM) to discovery and development of new oncological therapies that respond to important unmet medical needs.
more information